News & Perspective

Jul 28, 2016

Jul 28, 2016
Microbiology lab technician

Public-private partnership aims to spur new antibiotics

The US-UK partnership will provide $44 million this year and as much as $350 million over 5 years.

Oct 18, 2011

Oct 18, 2011

Anthrax countermeasures better than in 2001, but work remains

(CIDRAP News) – If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.

Apr 29, 2009

Apr 29, 2009

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Aug 16, 2005

Aug 16, 2005

US seeks stockpile of safer smallpox vaccine

Editor's note: This story was revised Aug 17 to add information on funding and a link to the government's request for proposals to supply the vaccine.

(CIDRAP News) – The US government has called for proposals to supply up to 80 million doses of a weakened smallpox vaccine to protect people for whom the conventional vaccine is too risky, according to two vaccine manufacturers.

Dec 14, 2004

Dec 14, 2004

Shortage spurs trial of GlaxoSmithKline flu vaccine

As part of efforts to improve the nation's long-term supply of influenza vaccine, the federal government is launching a clinical trial to help get a German-made vaccine licensed for regular use in the United States.

Oct 02, 2003

Oct 02, 2003

NIAID funds further development of new anthrax vaccines

(CIDRAP News) – The federal government awarded two contracts totaling more than $150 million this week for further testing and initial production of new anthrax vaccines designed to be safer and require fewer doses than the existing vaccine.

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»